Interim report January-September 2007

• Net sales increased by 9 percent to SEK 141.4 (129.5) million. Adjusted for exchange rate effects, the increase was 12 percent. During the third quarter sales amounted to SEK 44.6 (41.0) million, corresponding to an increase of 9 percent. Adjusted for negative exchange rate effects, the increase was 12 percent.

• Gross income increased by 11 percent to SEK 97.5 (87.6) million, and the gross margin improved to 69 percent (68). Gross income for the third quarter increased by 7 percent to SEK 30.5 (28.4) million and the gross margin was 68 (69) percent, despite extra costs in connection with the launch of a completely new product series.

• Operating income increased by 11 percent and amounted to SEK 17.9 (16.1) million, which gives an operating margin of 13 percent (12). For the third quarter operating income amounted to SEK 4.1 (6.5) million.

• Operating income before research and development costs increased by 10 percent to SEK 37.5 (34.2) million. This corresponds to a margin of 27 percent (26). For the third quarter operating income before research and development costs amounted to SEK 10.5 (12.6) million, a margin of 24 percent (31).

• Continued strong focus on research and development activities, 13.9 percent (14.0) of sales, 14.4 percent (14.9) for the third quarter.

• Consolidated net income increased to SEK 28.2 (13.1) million, of which SEK 7.7 (6.0) million was for the third quarter. Capitalization of the deferred tax asset in loss carry-forward for tax purposes has been carried out to the tune of SEK 12.3 (-) million, of which SEK 4.1 (-) million was for the third quarter.

• The cash flow from operating activities amounted to SEK 18.0 (18.4) million, of which SEK 5.6 (9.9) was for the third quarter.

• Earnings per share increased to SEK 1.42 (0.66) of which SEK 0.39 (0.30) was for the third quarter.

• The equity/assets ratio amounted to 83 percent (79).

• Launch of a new product series within Fertility, the G5 Series™.



October 25, 2007
Kungsbacka, Sweden

Magnus Nilsson
CEO


Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.